The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach

NCT01933724 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Granulomatosis With Polyangiitis
Wegener Granulomatosis
Vasculitis

Interventions

DRUG: 5 mg prednisone
DRUG: 0 mg prednisone

Sponsor

University of South Florida

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]